C-Path and EATRIS To Collaborate on RDCA-DAP

C-Path has signed a Memorandum of Understanding with EATRIS, the European infrastructure for translational medicine, to accelerate drug development for rare diseases by increasing the efficiency of translation of potential therapeutics through preclinical and clinical development.

C-Path and NORD co-hosted a virtual workshop on October 19, 2020 highlighting the milestones reached and future plans for the Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP) initiative. The workshop is a great chance to hear more about RDCA-DAP, learn about how the platform works and hear case studies on how sharing patient-level data accelerates understanding of rare diseases. You can view the 2020 RDCA-DAP Workshop in its entirety here: https://globalmeet.webcasts.com/starthere.jsp?ei=1354603&tp_key=d71908bac9